Skip to main navigation Skip to search Skip to main content

Should there be an age limit for advanced therapies?

Research output: Contribution to journalArticlepeer-review

Abstract

Combined heart lung transplant has become a rare procedure. However, there is a significant number of patients potentially benefitting from replacement of both heart and lungs. This represents a quite diverse patient population. Decisions in patient selection have to be adjusted to individual needs and distinct constellation of the patient. Age may be a risk factor, but should be carefully integrated into the evaluation of perioperative and long term risks.

Original languageEnglish
Pages (from-to)4446-4447
Number of pages2
JournalJournal of Cardiac Surgery
Volume37
Issue number12
DOIs
StatePublished - Dec 2022

Bibliographical note

Publisher Copyright:
© 2022 Wiley Periodicals LLC.

Keywords

  • age limit
  • heart lung transplant
  • patient selection

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Should there be an age limit for advanced therapies?'. Together they form a unique fingerprint.

Cite this